Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.189. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0240
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institutes of Health
Grant: 5R01CA267691-04
Uncovering the basis and implications of lineage plasticity in breast cancer
National Institutes of Health
Grant: 3P30CA023108-41S8
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA262232-02
Therapeutically leveraging metabolic vulnerabilities in breast cancer
National Institutes of Health
Grant: 1F31CA243409-01A1
Estrogen therapy for anti-estrogen resistant disease: Uncovering molecular mechanisms of response
National Institutes of Health
Grant: 1R01CA211869-01A1
Timing is everything: applications in precision oncology for ER+ breast cancer
National Institutes of Health
Grant: 5R01CA200994-07
A precision medicine basis for estrogen therapy for advanced breast cancer
National Institutes of Health
Grant: 3P20GM130454-05S2
NOSI cloud computing Supplement
NIGMS NIH HHS
Grant: P20 GM130454
Fields of Study
Keywords
Sustainable Development Goals